Seed · Biotech · Zurich, Switzerland · Founded 2016 · 10–12 employees
PharmaBiome AG is a pre-clinical biotech spinoff from ETH Zurich developing a drug platform for targeted microbiome therapeutics using beneficial gut bacteria to treat diseases like ulcerative colitis. It leverages proprietary technology for isolation, cultivation, and assembly of intestinal bacterial mixtures, aiming for clinical trials in 2025. Notable partnerships include Ferring for R&D and licensing, and Roquette for microbiome-modifying fibers; it raised CHF 1.75M bridge funding in 2020 and received awards like Spark Award 2018.
No open roles listed right now.